• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人工智能与神经心理学测量:以阿尔茨海默病为例。

Artificial intelligence and neuropsychological measures: The case of Alzheimer's disease.

作者信息

Battista Petronilla, Salvatore Christian, Berlingeri Manuela, Cerasa Antonio, Castiglioni Isabella

机构信息

Scientific Clinical Institutes Maugeri IRCCS, Institute of Bari, Pavia, Italy.

Department of Science, Technology and Society, Scuola Universitaria Superiore IUSS Pavia, Piazza della Vittoria 15, 27100 Pavia, Italy; DeepTrace Technologies S.r.l., Via Conservatorio 17, 20122 Milan, Italy.

出版信息

Neurosci Biobehav Rev. 2020 Jul;114:211-228. doi: 10.1016/j.neubiorev.2020.04.026. Epub 2020 May 11.

DOI:10.1016/j.neubiorev.2020.04.026
PMID:32437744
Abstract

One of the current challenges in the field of Alzheimer's disease (AD) is to identify patients with mild cognitive impairment (MCI) that will convert to AD. Artificial intelligence, in particular machine learning (ML), has established as one of more powerful approach to extract reliable predictors and to automatically classify different AD phenotypes. It is time to accelerate the translation of this knowledge in clinical practice, mainly by using low-cost features originating from the neuropsychological assessment. We performed a meta-analysis to assess the contribution of ML and neuropsychological measures for the automated classification of MCI patients and the prediction of their conversion to AD. The pooled sensitivity and specificity of patients' classifications was obtained by means of a quantitative bivariate random-effect meta-analytic approach. Although a high heterogeneity was observed, the results of meta-analysis show that ML applied to neuropsychological measures can lead to a successful automatic classification, being more specific as screening rather than prognosis tool. Relevant categories of neuropsychological tests can be extracted by ML that maximize the classification accuracy.

摘要

阿尔茨海默病(AD)领域当前面临的挑战之一是识别出将转化为AD的轻度认知障碍(MCI)患者。人工智能,尤其是机器学习(ML),已成为提取可靠预测指标并自动对不同AD表型进行分类的更强大方法之一。现在是时候加速将这些知识转化到临床实践中了,主要是通过使用源自神经心理学评估的低成本特征。我们进行了一项荟萃分析,以评估ML和神经心理学测量对MCI患者自动分类及其转化为AD的预测的贡献。通过定量双变量随机效应荟萃分析方法获得患者分类的合并敏感性和特异性。尽管观察到高度异质性,但荟萃分析结果表明,应用于神经心理学测量的ML可导致成功的自动分类,作为筛查工具比作为预后工具更具特异性。ML可以提取出能使分类准确性最大化的相关神经心理学测试类别。

相似文献

1
Artificial intelligence and neuropsychological measures: The case of Alzheimer's disease.人工智能与神经心理学测量:以阿尔茨海默病为例。
Neurosci Biobehav Rev. 2020 Jul;114:211-228. doi: 10.1016/j.neubiorev.2020.04.026. Epub 2020 May 11.
2
A Machine Learning-Based Holistic Approach to Predict the Clinical Course of Patients within the Alzheimer's Disease Spectrum.基于机器学习的阿尔茨海默病谱患者临床病程预测的整体方法。
J Alzheimers Dis. 2022;85(4):1639-1655. doi: 10.3233/JAD-210573.
3
Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer's disease: a feature selection ensemble combining stability and predictability.神经心理学预测指标在轻度认知障碍向阿尔茨海默病转化中的作用:一种结合稳定性和可预测性的特征选择集成。
BMC Med Inform Decis Mak. 2018 Dec 19;18(1):137. doi: 10.1186/s12911-018-0710-y.
4
A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.基于社区的研究,使用人工智能和机器学习识别轻度认知障碍和阿尔茨海默病的代谢生物标志物。
J Alzheimers Dis. 2020;78(4):1381-1392. doi: 10.3233/JAD-200305.
5
Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.两种言语记忆测量方法联合应用对阿尔茨海默病所致轻度认知障碍的诊断及预后价值
J Alzheimers Dis. 2017;58(3):909-918. doi: 10.3233/JAD-170073.
6
Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia.结合脑脊液生物标志物与神经心理学评估:一种预测从轻度认知障碍进展为阿尔茨海默病痴呆的简单且具成本效益的算法
J Alzheimers Dis. 2016 Oct 18;54(4):1495-1508. doi: 10.3233/JAD-160360.
7
Machine Learning Analysis of Digital Clock Drawing Test Performance for Differential Classification of Mild Cognitive Impairment Subtypes Versus Alzheimer's Disease.机器学习分析数字时钟绘画测试表现,用于区分轻度认知障碍亚型与阿尔茨海默病。
J Int Neuropsychol Soc. 2020 Aug;26(7):690-700. doi: 10.1017/S1355617720000144. Epub 2020 Mar 23.
8
A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.一种参数高效的深度学习方法,用于预测轻度认知障碍向阿尔茨海默病的转化。
Neuroimage. 2019 Apr 1;189:276-287. doi: 10.1016/j.neuroimage.2019.01.031. Epub 2019 Jan 14.
9
Neuropsychological Measures that Predict Progression from Mild Cognitive Impairment to Alzheimer's type dementia in Older Adults: a Systematic Review and Meta-Analysis.神经心理学测量在预测老年人从轻度认知障碍到阿尔茨海默病型痴呆的进展中的作用:系统评价和荟萃分析。
Neuropsychol Rev. 2017 Dec;27(4):328-353. doi: 10.1007/s11065-017-9361-5. Epub 2017 Oct 10.
10
Neuropsychological Contribution to Predict Conversion to Dementia in Patients with Mild Cognitive Impairment Due to Alzheimer's Disease.神经心理学对预测阿尔茨海默病导致轻度认知障碍患者向痴呆转化的贡献。
J Alzheimers Dis. 2020;74(3):785-796. doi: 10.3233/JAD-191133.

引用本文的文献

1
Deep learning of conversation-based 'filmstrips' for robust Alzheimer's disease detection.基于对话的“幻灯片”深度学习用于稳健的阿尔茨海默病检测。
NPJ Aging. 2025 Aug 29;11(1):77. doi: 10.1038/s41514-025-00267-4.
2
A Feature-Augmented Explainable Artificial Intelligence Model for Diagnosing Alzheimer's Disease from Multimodal Clinical and Neuroimaging Data.一种用于从多模态临床和神经影像数据中诊断阿尔茨海默病的特征增强可解释人工智能模型。
Diagnostics (Basel). 2025 Aug 17;15(16):2060. doi: 10.3390/diagnostics15162060.
3
Digital phenotyping of Parkinson's disease via natural language processing.
通过自然语言处理对帕金森病进行数字表型分析。
NPJ Parkinsons Dis. 2025 Jun 23;11(1):182. doi: 10.1038/s41531-025-01050-8.
4
AI-based staging, causal hypothesis and progression of subjects at risk of Alzheimer's disease: a multicenter study.基于人工智能的阿尔茨海默病高危受试者的分期、因果假设及病情进展:一项多中心研究
Front Neurol. 2025 May 19;16:1568086. doi: 10.3389/fneur.2025.1568086. eCollection 2025.
5
Digital Phenotyping of Parkinson's Disease via Natural Language Processing.通过自然语言处理对帕金森病进行数字表型分析。
Res Sq. 2025 Feb 18:rs.3.rs-6017580. doi: 10.21203/rs.3.rs-6017580/v1.
6
An experimental framework for conjoint measures of olfaction, navigation, and motion as pre-clinical biomarkers of Alzheimer's disease.作为阿尔茨海默病临床前生物标志物的嗅觉、导航和运动联合测量的实验框架。
J Alzheimers Dis Rep. 2024 Dec 23;8(1):1722-1744. doi: 10.1177/25424823241307617. eCollection 2024.
7
Predicting conversion in cognitively normal and mild cognitive impairment individuals with machine learning: Is the CSF status still relevant?运用机器学习预测认知正常和轻度认知障碍个体的病情转化:脑脊液状态是否仍具有相关性?
Alzheimers Dement. 2025 Feb;21(2):e14398. doi: 10.1002/alz.14398. Epub 2025 Jan 30.
8
Preclinical Cognitive Markers of Alzheimer Disease and Early Diagnosis Using Virtual Reality and Artificial Intelligence: Literature Review.阿尔茨海默病的临床前认知标志物以及使用虚拟现实和人工智能的早期诊断:文献综述
JMIR Med Inform. 2025 Jan 28;13:e62914. doi: 10.2196/62914.
9
AI-assisted neurocognitive assessment protocol for older adults with psychiatric disorders.针对患有精神疾病的老年人的人工智能辅助神经认知评估方案。
Front Psychiatry. 2025 Jan 13;15:1516065. doi: 10.3389/fpsyt.2024.1516065. eCollection 2024.
10
A machine learning prediction model for Cardiac Amyloidosis using routine blood tests in patients with left ventricular hypertrophy.一种使用常规血液检测对左心室肥厚患者的心脏淀粉样变性进行机器学习预测的模型。
Sci Rep. 2024 Nov 19;14(1):28644. doi: 10.1038/s41598-024-77466-8.